Twist Bioscience stock gains 1.43% as authors use company DNA for citrullinemia type I study

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience rises 1.43% today

Highlights

TWST maintains strong bullish momentum, trading well above key moving averages across all time frames.
Technical indicators show widespread overbought conditions, suggesting potential for near-term profit-taking or volatility.
TWST is expected to consolidate between $81.00 and $90.50 next week, with a breakout above $90.50 targeting new highs.

The work provides insights into variant pathogenicity and epistatic interactions. The study is published in PLOS Genetics.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Sustained bullish bias as price holds above multi-timeframe supports

TWST is trading well above its MA-20 ($72.92), MA-50 ($63.18), and MA-200 ($43.48), indicating strong bullish momentum across short-, medium-, and long-term trends. The Ichimoku Kijun sits at $68.45, below the current price, serving as immediate support.

Strong momentum faces overbought risk amid intraday consolidation

MACD and ADX on D1 suggest robust bullish momentum, but overbought signals from RSI (69.90), Stoch RSI, and CCI highlight the possibility of near-term profit-taking. BBP registers as overbought at 11.34, confirming that buyers continue to dominate intraday price action. The Awesome Oscillator also supports the current upside trend. In today's session, TWST has climbed 1.43%, recovering from weekly lows. Over the past week, TWST has slipped $1.17 (1.46%) from the previous weekly close ($87.56), now trading in the middle of its weekly range. Weekly volatility stands at 9.91%. The pattern shows consolidation after an earlier high, with momentum cooling but no decisive reversal.

Higher probability of upside as technical signals outweigh downside risk

Looking ahead, the expected price range for the coming week is $81.00 to $90.50. This forecast anchors TWST well above its 52-week low ($23.30) and just below its 52-week high ($89.71), reflecting its strong yearly advance. Based on bullish signals from RSI-W1, ADX-W1, MACD-W1, and MA-50-W1, there is a very high probability (more than 80%) that the price will move higher. The likelihood of a weekly decline is much lower. In the baseline scenario, TWST consolidates between $81.00 and $90.50. A bullish breakout above $90.50 could target new highs, extending the uptrend. Conversely, a drop below $81.00 would open the door to a corrective move, with next key support around the MA-50.

Earlier, analysts noted that Twist Bioscience maintained firm bullish momentum across multiple timeframes, with technical signals favoring further consolidation after notable gains. This article provides an updated view on current developments, highlighting new risks and opportunities for traders as the trend evolves.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.